Rossari Biotech’s revenue beat our estimate (+2.8%) due to strong volume growth in HPPC (Home, Personal Care, and Performance Chemicals) business and in the TSC (Textile Specialty Chemicals) division.We anticipate this growth momentum in revenue will continue due to strong demand in the end customer segments.